Compare Stocks: MYO, RCEL, STEX, and CVRX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$5.18 -3.7%	$5.30	$4.37 ▼ $11.30	$137.46M	0.81	324,725 shs	95,412 shs
MYO Myomo	$1.01 +1.0%	$1.13	$0.61 ▼ $2.02	$39.03M	1.47	577,325 shs	329,459 shs
RCEL Avita Medical	$4.40 -2.0%	$4.39	$3.22 ▼ $7.12	$135.42M	1.86	256,015 shs	121,111 shs
STEX Biosig Technologies	$0.71 -5.2%	$0.96	$0.66 ▼ $7.44	$129.06M	1.94	1.80 million shs	731,947 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	+8.58%	+10.02%	+4.67%	-28.36%	-34.87%
MYO Myomo	+7.52%	0.00%	-3.85%	+16.33%	-49.24%
RCEL Avita Medical	+1.13%	-2.60%	+8.72%	+3.94%	-16.23%
STEX Biosig Technologies	+8.77%	-1.98%	-11.93%	-2.13%	+74,889,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$5.18 -3.7%	$5.30	$4.37 ▼ $11.30	$137.46M	0.81	324,725 shs	95,412 shs
MYO Myomo	$1.01 +1.0%	$1.13	$0.61 ▼ $2.02	$39.03M	1.47	577,325 shs	329,459 shs
RCEL Avita Medical	$4.40 -2.0%	$4.39	$3.22 ▼ $7.12	$135.42M	1.86	256,015 shs	121,111 shs
STEX Biosig Technologies	$0.71 -5.2%	$0.96	$0.66 ▼ $7.44	$129.06M	1.94	1.80 million shs	731,947 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	+8.58%	+10.02%	+4.67%	-28.36%	-34.87%
MYO Myomo	+7.52%	0.00%	-3.85%	+16.33%	-49.24%
RCEL Avita Medical	+1.13%	-2.60%	+8.72%	+3.94%	-16.23%
STEX Biosig Technologies	+8.77%	-1.98%	-11.93%	-2.13%	+74,889,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVRX CVRx	2.67	Moderate Buy	$11.50	122.01% Upside
MYO Myomo	3.00	Buy	$7.50	642.57% Upside
RCEL Avita Medical	2.43	Hold	$7.25	64.77% Upside
STEX Biosig Technologies	2.00	Hold	$8.00	1,026.92% Upside

Current Analyst Ratings Breakdown

Latest MYO, RCEL, STEX, and CVRX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/29/2026	STEX Biosig Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/30/2026	RCEL Avita Medical	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/24/2026	RCEL Avita Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/8/2026	MYO Myomo	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$9.50 ➝ $10.00
5/21/2026	STEX Biosig Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$9.00 ➝ $8.00
5/15/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$3.50 ➝ $6.00
5/6/2026	CVRX CVRx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
5/1/2026	STEX Biosig Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVRX CVRx	$59.07M	2.33	N/A	N/A	$1.50 per share	3.45
MYO Myomo	$40.93M	0.95	N/A	N/A	$0.30 per share	3.37
RCEL Avita Medical	$72.35M	1.87	N/A	N/A	($0.55) per share	-8.00
STEX Biosig Technologies	$40K	3,226.50	N/A	N/A	$0.83 per share	0.86

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVRX CVRx	-$53.31M	-$2.02	N/A	N/A	N/A	-89.14%	-120.76%	-48.38%	8/6/2026 (Estimated)
MYO Myomo	-$15.57M	-$0.23	N/A	N/A	N/A	-36.69%	-119.60%	-42.50%	8/5/2026 (Confirmed)
RCEL Avita Medical	-$48.59M	-$1.57	N/A	N/A	N/A	-62.67%	N/A	-78.92%	8/6/2026 (Estimated)
STEX Biosig Technologies	-$462.77M	-$9.71	N/A	N/A	N/A	N/A	-717.92%	-336.75%	N/A

Latest MYO, RCEL, STEX, and CVRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	MYO Myomo	-$0.10	N/A	N/A	N/A	$10.35 million	N/A
8/6/2026	Q2 2026	CVRX CVRx	-$0.52	N/A	N/A	N/A	$15.55 million	N/A
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	N/A	N/A	N/A	$20.25 million	N/A
5/14/2026	Q1 2026	RCEL Avita Medical	-$0.35	-$0.35	N/A	-$7.00	$18.30 million	$19.25 million
5/14/2026	Q1 2026	STEX Biosig Technologies	N/A	-$0.27	N/A	-$0.27	N/A	N/A
5/11/2026	Q1 2026	CVRX CVRx	-$0.51	-$0.50	+$0.01	-$0.50	$14.49 million	$14.77 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVRX CVRx	N/A	N/A	N/A	N/A	N/A
MYO Myomo	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A
STEX Biosig Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVRX CVRx	2.01	10.20	8.89
MYO Myomo	1.21	2.73	2.36
RCEL Avita Medical	N/A	0.47	0.38
STEX Biosig Technologies	N/A	13.90	13.90

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVRX CVRx	75.27%
MYO Myomo	44.99%
RCEL Avita Medical	27.66%
STEX Biosig Technologies	7.16%

Insider Ownership

Company	Insider Ownership
CVRX CVRx	13.90%
MYO Myomo	12.14%
RCEL Avita Medical	2.24%
STEX Biosig Technologies	52.73%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVRX CVRx	160	26.54 million	22.85 million	Optionable
MYO Myomo	90	38.64 million	33.95 million	Not Optionable
RCEL Avita Medical	130	30.78 million	30.09 million	Optionable
STEX Biosig Technologies	50	181.80 million	85.94 million	N/A

MYO, RCEL, STEX, and CVRX Headlines

Recent News About These Companies

Critical Analysis: Biosig Technologies (NASDAQ:STEX) & Conexeu Sciences (NASDAQ:CNXU)

July 31 at 1:58 AM | americanbankingnews.com

Streamex Corp. Details GLDY's Liquidity Infrastructure; ~$12 Million in Seeded Liquidity Supports 24/7, 365 Instant Trading Across Multiple Institutional-Grade Venues

July 23, 2026 | globenewswire.com

Streamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with Wintermute

July 23, 2026 | globenewswire.com

Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors

July 21, 2026 | globenewswire.com

Biosig Technologies (NASDAQ:STEX) & Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Head-To-Head Review

July 20, 2026 | americanbankingnews.com

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) versus Biosig Technologies (NASDAQ:STEX) Financial Comparison

July 20, 2026 | americanbankingnews.com

Wall Street Zen Downgrades Biosig Technologies (NASDAQ:STEX) to Strong Sell

July 18, 2026 | marketbeat.com

Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY

July 17, 2026 | globenewswire.com

Streamex GLDY Clears Key Trust Milestone With First Independent Gold Reserve Attestation

July 8, 2026 | thenewswire.comT

Streamex Corp. Announces 10,000,000 Share Repurchase Program

July 7, 2026 | globenewswire.com

Streamex Yield-Bearing Gold Asset GLDY Just Went Mainstream

July 2, 2026 | thenewswire.comT

Streamex Corp. Announces First Independent Reserve Attestation by EisnerAmper for GLDY

July 1, 2026 | globenewswire.com

Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO

June 29, 2026 | globenewswire.com

Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY

June 22, 2026 | globenewswire.com

Biosig Technologies (NASDAQ:STEX) Chairman Morgan Lee Lekstrom Purchases 50,000 Shares

June 16, 2026 | insidertrades.com

Biosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Sells 23,810 Shares

June 3, 2026 | insidertrades.com

[Video Enhanced] Streamex has Created a Compliant Secondary Market for Real World Assets

June 2, 2026 | thenewswire.comT

Insider Buying: Biosig Technologies (NASDAQ:STEX) Chairman Buys 34,000 Shares of Stock

May 29, 2026 | insidertrades.com

[Video Enhanced] Streamex Adds Microsoft and PayPal Lead Product Designer to High-Level Talent Roster

May 28, 2026 | thenewswire.comT

Streamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural Asset

May 27, 2026 | globenewswire.com

Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

May 26, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MYO, RCEL, STEX, and CVRX Company Descriptions

CVRx NASDAQ:CVRX

$5.18 -0.20 (-3.72%)

Closing price 04:00 PM Eastern

Extended Trading

$5.20 +0.03 (+0.48%)

As of 04:20 PM Eastern

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Myomo NYSEAMERICAN:MYO

$1.01 +0.01 (+1.00%)

Closing price 04:10 PM Eastern

Extended Trading

$1.00 -0.01 (-0.50%)

As of 07:47 PM Eastern

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Avita Medical NASDAQ:RCEL

$4.40 -0.09 (-2.00%)

Closing price 04:00 PM Eastern

Extended Trading

$4.42 +0.02 (+0.57%)

As of 07:34 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Biosig Technologies NASDAQ:STEX

$0.71 -0.04 (-5.21%)

Closing price 04:00 PM Eastern

Extended Trading

$0.70 -0.01 (-0.97%)

As of 07:20 PM Eastern

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MYO, RCEL, STEX, and CVRX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MYO, RCEL, STEX, and CVRX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MYO, RCEL, STEX, and CVRX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MYO, RCEL, STEX, and CVRX Company Descriptions

CVRx NASDAQ:CVRX

Myomo NYSEAMERICAN:MYO

Avita Medical NASDAQ:RCEL

Biosig Technologies NASDAQ:STEX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MYO, RCEL, STEX, and CVRX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MYO, RCEL, STEX, and CVRX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MYO, RCEL, STEX, and CVRX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MYO, RCEL, STEX, and CVRX Company Descriptions

CVRx NASDAQ:CVRX

Myomo NYSEAMERICAN:MYO

Avita Medical NASDAQ:RCEL

Biosig Technologies NASDAQ:STEX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools